• Je něco špatně v tomto záznamu ?

The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins

C. Tempra, C. La Rosa, F. Lolicato

. 2021 ; 236 (-) : 105061. [pub] 20210218

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004381

The most accredited hypothesis links the toxicity of amyloid proteins to their harmful effects on membrane integrity through the formation of prefibrillar-transient oligomers able to disrupt cell membranes. However, damage mechanisms necessarily assume a first step in which the amyloidogenic protein transfers from the aqueous phase to the membrane hydrophobic core. This determinant step is still poorly understood. However, according to our lipid-chaperon hypothesis, free lipids in solution play a crucial role in facilitating this footfall. Free phospholipid concentration in the aqueous phase acts as a switch between ion channel-like pore and fibril formation, so that high free lipid concentration in solution promotes pore and repress fibril formation. Conversely, low free lipids in the solution favor fibril and repress pore formation. This behavior is due to the formation of stable lipid-protein complexes. Here, we hypothesize that the helix propensity is a fundamental requirement to fulfill the lipid-chaperon model. The alpha-helix region seems to be responsible for the binding with amphiphilic molecules fostering the proposed mechanism. Indeed, our results show the dependency of protein-lipid binding from the helical structure presence. When the helix content is substantially lower than the wild type, the contact probability decreases. Instead, if the helix is broadening, the contact probability increases. Our findings open a new perspective for in silico screening of secondary structure-targeting drugs of amyloidogenic proteins.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004381
003      
CZ-PrNML
005      
20220127145311.0
007      
ta
008      
220113s2021 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.chemphyslip.2021.105061 $2 doi
035    __
$a (PubMed)33610597
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Tempra, Carmelo $u Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic
245    14
$a The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins / $c C. Tempra, C. La Rosa, F. Lolicato
520    9_
$a The most accredited hypothesis links the toxicity of amyloid proteins to their harmful effects on membrane integrity through the formation of prefibrillar-transient oligomers able to disrupt cell membranes. However, damage mechanisms necessarily assume a first step in which the amyloidogenic protein transfers from the aqueous phase to the membrane hydrophobic core. This determinant step is still poorly understood. However, according to our lipid-chaperon hypothesis, free lipids in solution play a crucial role in facilitating this footfall. Free phospholipid concentration in the aqueous phase acts as a switch between ion channel-like pore and fibril formation, so that high free lipid concentration in solution promotes pore and repress fibril formation. Conversely, low free lipids in the solution favor fibril and repress pore formation. This behavior is due to the formation of stable lipid-protein complexes. Here, we hypothesize that the helix propensity is a fundamental requirement to fulfill the lipid-chaperon model. The alpha-helix region seems to be responsible for the binding with amphiphilic molecules fostering the proposed mechanism. Indeed, our results show the dependency of protein-lipid binding from the helical structure presence. When the helix content is substantially lower than the wild type, the contact probability decreases. Instead, if the helix is broadening, the contact probability increases. Our findings open a new perspective for in silico screening of secondary structure-targeting drugs of amyloidogenic proteins.
650    _2
$a amyloidogenní proteiny $x chemie $x genetika $7 D058227
650    12
$a racionální návrh léčiv $7 D015195
650    _2
$a lidé $7 D006801
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a konformace proteinů, alfa-helix $7 D000072756
655    _2
$a časopisecké články $7 D016428
700    1_
$a La Rosa, Carmelo $u University of Catania, Catania, Italy. Electronic address: clarosa@unict.it
700    1_
$a Lolicato, Fabio $u Heidelberg University Biochemistry Center, Heidelberg, Germany; Department of Physics, University of Helsinki, Helsinki, Finland. Electronic address: fabio.lolicato@bzh.uni-heidelberg.de
773    0_
$w MED00002119 $t Chemistry and physics of lipids $x 1873-2941 $g Roč. 236, č. - (2021), s. 105061
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33610597 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145308 $b ABA008
999    __
$a ok $b bmc $g 1751747 $s 1155530
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 236 $c - $d 105061 $e 20210218 $i 1873-2941 $m Chemistry and physics of lipids $n Chem Phys Lipids $x MED00002119
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...